Zhao L,Su KS,Ye Z,et al.Research advances on the clinical characteristics and diagnosis and treatment of autoimmune disease-related ulcers[J].Chin J Burns Wounds,2022,38(6):558-562.DOI: 10.3760/cma.j.cn501120-20211019-00358.
Citation: Zhao L,Su KS,Ye Z,et al.Research advances on the clinical characteristics and diagnosis and treatment of autoimmune disease-related ulcers[J].Chin J Burns Wounds,2022,38(6):558-562.DOI: 10.3760/cma.j.cn501120-20211019-00358.

Research advances on the clinical characteristics and diagnosis and treatment of autoimmune disease-related ulcers

doi: 10.3760/cma.j.cn501120-20211019-00358
Funds:

Jilin Provincial Health Special Project JLSWSRCZX2020-0038

More Information
  • Studies have shown that autoimmune disease (AID)-related ulcers are disease complications that lead to serious poor prognosis such as infection and disability. It is difficult to make a clear diagnosis and there are contradictions between the applications of immunosuppressive therapy and anti-infectious therapy. Improper diagnosis and immunosuppressive therapy can easily delay the timing of anti-infectious therapy and surgery for patients, which bring adverse effects on the prognosis of patients. This paper reviews the concept, clinical characteristics and treatment suggestions of each subtype of AID-related ulcers, in order to provide more ideas for AID-related ulcers' clinical diagnosis and treatment.

     

  • [1]
    SuzukiE,KyozukaH,NishidaT,et al.Systemic lupus erythematosus, complicated with refractory skin ulcers, treated successfully with bosentan[J].Mod Rheumatol,2009,19(4):447-451.DOI: 10.1007/s10165-009-0184-y.
    [2]
    LeaperDJ, SchultzG, CarvilleK, et al. Extending the TIME concept: what have we learned in the past 10 years?*[J]. Int Wound J, 2012,9 (Suppl 2):S1-19. DOI: 10.1111/j.1742-481X.2012.01097.x
    [3]
    BroughtonG2nd,JanisJE,AttingerCE.Wound healing: an overview[J].Plast Reconstr Surg,2006,117(7 Suppl):1e-S-32e-S.DOI: 10.1097/01.prs.0000222562.60260.f9.
    [4]
    MűzesG, SiposF. Primary immunodeficiency and autoimmune diseases[J]. Orv Hetil, 2018,159(23):908-918. DOI: 10.1556/650.2018.31064.
    [5]
    Amaya-UribeL,RojasM,AziziG,et al.Primary immunodeficiency and autoimmunity: a comprehensive review[J].J Autoimmun,2019,99:52-72.DOI: 10.1016/j.jaut.2019.01.011.
    [6]
    MaysJW,SarmadiM,MoutsopoulosNM.Oral manifestations of systemic autoimmune and inflammatory diseases: diagnosis and clinical management[J].J Evid Based Dent Pract,2012,12(3 Suppl):S265-282.DOI: 10.1016/S1532-3382(12)70051-9.
    [7]
    LoraV,CerroniL,CotaC.Skin manifestations of rheumatoid arthritis[J].G Ital Dermatol Venereol,2018,153(2):243-255.DOI: 10.23736/S0392-0488.18.05872-8.
    [8]
    GhoshSK, BandyopadhyayD, BiswasSK, et al. Mucocutaneous manifestations in patients with rheumatoid arthritis: a cross-sectional study from Eastern India[J]. Indian J Dermatol, 2017,62(4):411-417. DOI: 10.4103/ijd.IJD_260_17.
    [9]
    OlivéA,RiverosA,JuárezP,et al.Rheumatoid vasculitis: study of 41 cases[J].Med Clin (Barc),2020,155(3):126-129.DOI: 10.1016/j.medcli.2020.01.024.
    [10]
    Chua-AguileraCJ,MöllerB,YawalkarN.Skin manifestations of rheumatoid arthritis, juvenile idiopathic arthritis, and spondyloarthritides[J].Clin Rev Allergy Immunol,2017,53(3):371-393.DOI: 10.1007/s12016-017-8632-5.
    [11]
    NarváezJ, Domingo-DomenechE, Gómez-VaqueroC, et al. Biological agents in the management of Felty's syndrome: a systematic review[J]. Semin Arthritis Rheum, 2012,41(5):658- 668. DOI: 10.1016/j.semarthrit.2011.08.008.
    [12]
    XueY,CohenJM,WrightNA,et al.Skin signs of rheumatoid arthritis and its therapy-induced cutaneous side effects[J].Am J Clin Dermatol,2016,17(2):147-162.DOI: 10.1007/s40257-015-0167-z.
    [13]
    SayahA,EnglishJC3rd.Rheumatoid arthritis: a review of the cutaneous manifestations[J].J Am Acad Dermatol,2005,53(2):191-209; quiz 210-212.DOI: 10.1016/j.jaad.2004.07.023.
    [14]
    SzekaneczZ,McInnesIB,SchettG,et al.Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases[J].Nat Rev Rheumatol,2021,17(10):585-595.DOI: 10.1038/s41584-021-00652-9.
    [15]
    GilliamJN,SontheimerRD.Distinctive cutaneous subsets in the spectrum of lupus erythematosus[J].J Am Acad Dermatol,1981,4(4):471-475.DOI: 10.1016/s0190-9622(81)80261-7.
    [16]
    SontheimerRD.The lexicon of cutaneous lupus erythematosus--a review and personal perspective on the nomenclature and classification of the cutaneous manifestations of lupus erythematosus[J].Lupus,1997,6(2):84-95.DOI: 10.1177/096120339700600203.
    [17]
    NevskayaT,GambleMP,PopeJE.A meta-analysis of avascular necrosis in systemic lupus erythematosus: prevalence and risk factors[J].Clin Exp Rheumatol,2017,35(4):700-710.
    [18]
    KallasR,GoldmanD,PetriMA.Cutaneous vasculitis in SLE[J].Lupus Sci Med,2020,7(1):e000411.DOI: 10.1136/lupus-2020-000411.
    [19]
    CaproniM,VerdelliA.An update on the nomenclature for cutaneous vasculitis[J].Curr Opin Rheumatol,2019,31(1):46-52.DOI: 10.1097/BOR.0000000000000563.
    [20]
    JennetteJC,FalkRJ,BaconPA,et al.2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides[J].Arthritis Rheum,2013,65(1):1-11.DOI: 10.1002/art.37715.
    [21]
    ShiraiT,ShirotaY,FujiiH,et al.Four distinct clinical phenotypes of vasculitis affecting medium-sized arteries[J].Scand J Rheumatol,2019,48(4):308-314.DOI: 10.1080/03009742.2018.1551965.
    [22]
    CriadoPR,MarquesGF,TCABMorita,et al.Epidemiological, clinical and laboratory profiles of cutaneous polyarteritis nodosa patients: report of 22 cases and literature review[J].Autoimmun Rev,2016,15(6):558-563.DOI: 10.1016/j.autrev.2016.02.010.
    [23]
    BulurI,OnderM.Behçet disease: new aspects[J].Clin Dermatol,2017,35(5):421-434.DOI: 10.1016/j.clindermatol.2017.06.004.
    [24]
    MatMC,SevimA,FreskoI,et al.Behçet's disease as a systemic disease[J].Clin Dermatol,2014,32(3):435-442.DOI: 10.1016/j.clindermatol.2013.11.012.
    [25]
    ObataS,KobayashiK,TodaM,et al.Genital ulcer of behçet disease localized in the vagina may lack pain, making it difficult to assess[J].Case Rep Rheumatol,2019,2019:2953676.DOI: 10.1155/2019/2953676.
    [26]
    BuntrockA,McNamaraM,TantoushH,et al.Worsening of behcet syndrome symptoms during pregnancy[J].S D Med,2021,74(3):112-114.
    [27]
    GeneraliE,CostanzoA,MainettiC,et al.Cutaneous and mucosal manifestations of Sjögren's syndrome[J].Clin Rev Allergy Immunol,2017,53(3):357-370.DOI: 10.1007/s12016-017-8639-y.
    [28]
    DamoiseauxJ.The diagnosis and classification of the cryoglobulinemic syndrome[J].Autoimmun Rev,2014,13(4/5):359-362.DOI: 10.1016/j.autrev.2014.01.027.
    [29]
    Ramos-CasalsM,Brito-ZerónP,SerorR,et al.Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements[J].Rheumatology (Oxford),2015,54(12):2230-2238.DOI: 10.1093/rheumatology/kev200.
    [30]
    CentalaS,ParkJH,GirnitaD.Sjogren's syndrome presenting with solely cutaneous features[J].Diagnostics (Basel),2021,11(7):1260.DOI: 10.3390/diagnostics11071260.
    [31]
    DeWaneME,WaldmanR,LuJ.Dermatomyositis: clinical features and pathogenesis[J].J Am Acad Dermatol,2020,82(2):267-281.DOI: 10.1016/j.jaad.2019.06.1309.
    [32]
    BogdanovI,KazandjievaJ,DarlenskiR,et al.Dermatomyositis: current concepts[J].Clin Dermatol,2018,36(4):450-458.DOI: 10.1016/j.clindermatol.2018.04.003.
    [33]
    KurtzmanDJB, VleugelsRA. Anti-melanoma differentiation- associated gene 5 (MDA5) dermatomyositis: a concise review with an emphasis on distinctive clinical features[J].J Am Acad Dermatol,2018,78(4):776-785.DOI: 10.1016/j.jaad.2017.12.010.
    [34]
    NarangNS,Casciola-RosenL,LiSF,et al.Cutaneous ulceration in dermatomyositis: association with anti-melanoma differentiation- associated gene 5 antibodies and interstitial lung disease[J].Arthritis Care Res (Hoboken),2015,67(5):667-672.DOI: 10.1002/acr.22498.
    [35]
    GuillevinL,HunscheE,DentonCP,et al.Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO Registry[J].Clin Exp Rheumatol,2013,31(2 Suppl 76):S71-80.
    [36]
    MerkelPA,HerlynK,MartinRW,et al.Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon[J].Arthritis Rheum,2002,46(9):2410- 2420.DOI: 10.1002/art.10486.
    [37]
    PearsonDR,WerthVP,Pappas-TafferL.Systemic sclerosis: current concepts of skin and systemic manifestations[J].Clin Dermatol,2018,36(4):459-474.DOI: 10.1016/j.clindermatol.2018.04.004.
    [38]
    吴超,晋红中.坏疽性脓皮病的辅助检查及治疗[J].中华临床免疫和变态反应杂志,2019,13(4):301-305.DOI: 10.3969/j.issn.1673-8705.2019.04.010.
    [39]
    Julve-HerraizL,Villalba-FerrerF,García-CoretMJ,et al.Care and treatment of peristomal gangrenous pyoderma. A study of three cases[J].Enferm Clin (Engl Ed),2021,31(2):120-125.DOI: 10.1016/j.enfcli.2020.11.004.
    [40]
    唐锦明,祁少海,毛任翔,等.自身免疫性风湿病患者皮肤溃疡的临床特点与治疗策略[J/CD].中华损伤与修复杂志:电子版,2009,4(5):545-554.DOI: 10.3969/j.issn.1673-9450.2009.05.008.
    [41]
    VeselyMD.Getting under the skin: targeting cutaneous autoimmune disease[J].Yale J Biol Med,2020,93(1):197-206.
    [42]
    BusadaJT,CidlowskiJA.Mechanisms of glucocorticoid action during development[J].Curr Top Dev Biol,2017,125:147-170.DOI: 10.1016/bs.ctdb.2016.12.004.
    [43]
    Kowal-BieleckaO,FransenJ,AvouacJ,et al.Update of EULAR recommendations for the treatment of systemic sclerosis[J].Ann Rheum Dis,2017,76(8):1327-1339.DOI: 10.1136/annrheumdis-2016-209909.
    [44]
    StuckAE,MinderCE,FreyFJ.Risk of infectious complications in patients taking glucocorticosteroids[J].Rev Infect Dis,1989,11(6):954-963.DOI: 10.1093/clinids/11.6.954.
    [45]
    DerekE,DhanireddyK.Immunosuppression[J].Curr Opin Organ Transplant,2012,17(6):616-618.DOI: 10.1097/MOT.0b013e32835a7d3a.
    [46]
    SchuppeH,Richter-HintzD,StierleHE,et al.Topical tacrolimus for recalcitrant leg ulcer in rheumatoid arthritis[J].Rheumatology (Oxford),2000,39(1):105-106.DOI: 10.1093/rheumatology/39.1.105.
    [47]
    BettuzziT,JachietM,SbidianE,et al.Efficacy and safety of treatments in cutaneous polyarteritis nodosa: a French observational retrospective study[J].J Am Acad Dermatol,2022,86(5):1035-1041.DOI: 10.1016/j.jaad.2021.06.872.
    [48]
    GoldustM,HagstromEL,RathodD,et al.Diagnosis and novel clinical treatment strategies for pyoderma gangrenosum[J].Expert Rev Clin Pharmacol,2020,13(2):157-161.DOI: 10.1080/17512433.2020.1709825.
    [49]
    OienRF,HåkanssonA,HansenBU.Leg ulcers in patients with rheumatoid arthritis--a prospective study of aetiology, wound healing and pain reduction after pinch grafting[J].Rheumatology (Oxford),2001,40(7):816-820.DOI: 10.1093/rheumatology/40.7.816.
    [50]
    HorwitzDA,FahmyTM,PiccirilloCA,et al.Rebalancing immune homeostasis to treat autoimmune diseases[J].Trends Immunol,2019,40(10):888-908.DOI: 10.1016/j.it.2019.08.003.
    [51]
    唐玉磊.褥疮护理新进展[J].中国老年保健医学,2007,5(4):143-144.DOI: 10.3969/j.issn.1672-4860-B.2007.04.091.
  • Relative Articles

    [1]Shen Yuming, Hu Yungang. Diagnosis and treatment strategies of chronic radiation ulcers[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2024, 40(6): 501-506. doi: 10.3760/cma.j.cn501225-20240308-00091
    [2]Xia Chengde, Yang Yang. Strategies for the treatment and prevention of radiation-induced skin ulcers[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2024, 40(8): 719-724. doi: 10.3760/cma.j.cn501225-20240415-00134
    [3]Zhang Lu, Wang Xingtong, Chu Wanli. Advances on the research and treatment of autoimmune disease-related chronic wounds[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2022, 38(6): 563-568. doi: 10.3760/cma.j.cn501225-20220329-00101
    [4]Li Shuntang, Lin Yuan, Ou Binxian, Liu Da'en, Li Dehui, Nong Qingwen, Wu Yajun, Qiu Shumei, Huang Zhenxing. Effects of comprehensive treatment of infected wounds in patients with iatrogenic Cushing's syndrome[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2022, 38(6): 512-519. doi: 10.3760/cma.j.cn501225-20220329-00106
    [5]Jia Rufu, Cao Mingcong. Interpretation of 2020 edition of Japanese "Guidelines for the management of connective tissue disease/vasculitis-associated skin ulcers"[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2022, 38(12): 1196-1200. doi: 10.3760/cma.j.cn501225-20220320-00073
    [6]Yu Jia'ao, Zhao Jingchun. Emphasis on multidisciplinary collaboration in clinical diagnosis and treatment of autoimmune disease-related ulcers[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2022, 38(6): 501-505. doi: 10.3760/cma.j.cn501120-20211112-00385
    [7]Jia Shanshan, Wang Xiaochuan, Jiao Ya, Jiang Duyin, Zhao Jie. Research advances on skin wounds suturing techniques and their clinical application[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2021, 37(11): 1099-1104. doi: 10.3760/cma.j.cn501120-20200701-00334
    [8]Chen Lan, Xie Weiguo, Yu Gang. A case of pseudotumor of lower extremity combined with protracted infectious skin ulcer induced by severe hemophilia A[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2021, 37(12): 1191-1193. doi: 10.3760/cma.j.cn501120-20200801-00366
    [9]Yang Minlie, Zhou Xiaojin, Zhu Yugang, Jiang Donglin, Ding Lintao, Chu Guoping, Zhao Peng, Cheng Jia, Lyu Guozhong, Li Qingfeng. Clinical efficacy and influencing factors of different modes of continuous negative pressure wound therapy on venous ulcer wounds of lower limbs[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2020, 36(12): 1149-1158. doi: 10.3760/cma.j.cn501120-20200316-00173
    [10]He Weifeng, Luo Gaoxing. Role of skin immunity on wound healing[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2020, 36(10): 901-904. doi: 10.3760/cma.j.cn501120-20200823-00389
    [11]Xin Yuewen, Chai Yanfen, Yao Yongming. Advances in the research of the relationship between skin regulatory T cells and wound healing and immune diseases[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2020, 36(2): 156-160. doi: 10.3760/cma.j.issn.1009-2587.2020.02.015
    [12]Yang Yi, Chu Wanli, Feng Guang, Zhang Haijun, Hao Daifeng. Retrospective analysis of 2 997 inpatients with skin and soft tissue injuries[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2020, 36(9): 821-829. doi: 10.3760/cma.j.cn501120-20200202-00036
    [13]Zhao Mingyu, Xu Gang, Li Pingsong, Luo Yi, Li Xiaomei. A case of chronic ulcer with ectopic ossification in lower right extremity[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2020, 36(5): 402-404. doi: 10.3760/cma.j.cn501120-20190408-00172
    [14]Ni Pengwen, Mao Beiqian, Yang Yi, Li Jingjing, Liu Hong, Huang Yao, Xie Ting. Study on the relationship between uncertainty in illness and caregiving burden in family members of patients with chronic wounds[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2019, 35(5): 379-383. doi: 10.3760/cma.j.issn.1009-2587.2019.05.010
    [15]Peng Ying, Zhao Yang, Xie Ying, Lin Xiaoying, Pan Manchang, Wang Hong. Effects of allogeneic skin fibroblasts on promoting wound healing of diabetic mice and the mechanism[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2018, 34(8): 532-541. doi: 10.3760/cma.j.issn.1009-2587.2018.08.011
    [16]Liu Yang, Hu Dahai. Advances in the research of molecular mechanism of negative pressure wound therapy in improving wound healing[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2017, 33(11): 718-720. doi: 10.3760/cma.j.issn.1009-2587.2017.11.015
    [17]Yao Yongming, Yan He, Zhang Zemin, Wu Caifeng, Zhang Liang, Yang Biaobing. Effects of rabbit adipose-derived mesenchymal stem cells on the healing of skin deep partial-thickness scald wound of rabbit[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2016, 32(7): 402-407. doi: 10.3760/cma.j.issn.1009-2587.2016.07.004
    [19]Niu Yiwen, Miao Mingyuan, Cao Xiaozan, Song Fei, Ji Xiaoyun, Dong Jiaoyun, Lu Shuliang. Infiltration of macrophages and their phenotype in the healing process of full-thickness wound in rat[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2014, 30(2): 109-115. doi: 10.3760/cma.j.issn.1009-2587.2014.02.004
    [20]HAN Chun-mao. Facing wound healing--let our mind soar[J]. CHINESE JOURNAL OF BURNS AND WOUNDS, 2012, 28(1): 3-4. doi: 10.3760/cma.j.issn.1009-2587.2012.01.002
  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-042024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-030510152025
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 9.6 %FULLTEXT: 9.6 %META: 84.8 %META: 84.8 %PDF: 5.7 %PDF: 5.7 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 3.1 %其他: 3.1 %其他: 0.6 %其他: 0.6 %Bass Hill: 0.1 %Bass Hill: 0.1 %China: 0.1 %China: 0.1 %India: 0.1 %India: 0.1 %Westbury: 0.1 %Westbury: 0.1 %[]: 1.7 %[]: 1.7 %三明: 0.8 %三明: 0.8 %三门峡: 0.7 %三门峡: 0.7 %上海: 0.8 %上海: 0.8 %东莞: 0.5 %东莞: 0.5 %临汾: 0.2 %临汾: 0.2 %丽水: 0.2 %丽水: 0.2 %乐山: 0.2 %乐山: 0.2 %佛山: 0.3 %佛山: 0.3 %保定: 1.5 %保定: 1.5 %六安: 0.5 %六安: 0.5 %六盘水: 0.4 %六盘水: 0.4 %兰州: 0.7 %兰州: 0.7 %兴安: 0.1 %兴安: 0.1 %北京: 1.2 %北京: 1.2 %北方邦: 0.1 %北方邦: 0.1 %南充: 0.2 %南充: 0.2 %南宁: 0.4 %南宁: 0.4 %南平: 1.8 %南平: 1.8 %南昌: 0.5 %南昌: 0.5 %南通: 0.5 %南通: 0.5 %台州: 0.4 %台州: 0.4 %合肥: 0.5 %合肥: 0.5 %吉林: 0.1 %吉林: 0.1 %吕梁: 0.1 %吕梁: 0.1 %呼伦贝尔: 0.1 %呼伦贝尔: 0.1 %呼和浩特: 0.1 %呼和浩特: 0.1 %哥伦布: 0.1 %哥伦布: 0.1 %唐山: 0.3 %唐山: 0.3 %商丘: 0.1 %商丘: 0.1 %嘉兴: 0.8 %嘉兴: 0.8 %夏洛特: 0.3 %夏洛特: 0.3 %大连: 0.8 %大连: 0.8 %天津: 0.1 %天津: 0.1 %太原: 0.1 %太原: 0.1 %宁德: 2.6 %宁德: 2.6 %宁波: 0.6 %宁波: 0.6 %安康: 0.4 %安康: 0.4 %宜春: 0.3 %宜春: 0.3 %宿迁: 1.9 %宿迁: 1.9 %常州: 0.2 %常州: 0.2 %常德: 0.4 %常德: 0.4 %广元: 0.2 %广元: 0.2 %广州: 0.8 %广州: 0.8 %延安: 1.1 %延安: 1.1 %开普敦: 0.3 %开普敦: 0.3 %张家口: 1.6 %张家口: 1.6 %徐州: 1.5 %徐州: 1.5 %德阳: 1.1 %德阳: 1.1 %怀化: 0.2 %怀化: 0.2 %成都: 1.3 %成都: 1.3 %扬州: 0.2 %扬州: 0.2 %拉合尔: 0.1 %拉合尔: 0.1 %拉贾斯坦邦: 0.4 %拉贾斯坦邦: 0.4 %无锡: 0.3 %无锡: 0.3 %日照: 0.6 %日照: 0.6 %昆明: 0.3 %昆明: 0.3 %晋城: 0.3 %晋城: 0.3 %杭州: 1.9 %杭州: 1.9 %桂林: 0.2 %桂林: 0.2 %梧州: 0.4 %梧州: 0.4 %榆林: 0.5 %榆林: 0.5 %武汉: 0.7 %武汉: 0.7 %汉中: 0.5 %汉中: 0.5 %汕头: 0.1 %汕头: 0.1 %池州: 0.9 %池州: 0.9 %沈阳: 0.8 %沈阳: 0.8 %沧州: 0.2 %沧州: 0.2 %泉州: 1.4 %泉州: 1.4 %泰州: 1.6 %泰州: 1.6 %泸州: 0.2 %泸州: 0.2 %济南: 0.8 %济南: 0.8 %海口: 0.2 %海口: 0.2 %海得拉巴: 0.3 %海得拉巴: 0.3 %淮安: 0.2 %淮安: 0.2 %温州: 0.3 %温州: 0.3 %渭南: 0.4 %渭南: 0.4 %湖州: 1.2 %湖州: 1.2 %湘潭: 0.2 %湘潭: 0.2 %湘西: 0.1 %湘西: 0.1 %湘西土家族苗族自治州: 0.3 %湘西土家族苗族自治州: 0.3 %滁州: 0.3 %滁州: 0.3 %漯河: 0.4 %漯河: 0.4 %漳州: 0.7 %漳州: 0.7 %潍坊: 0.4 %潍坊: 0.4 %烟台: 0.2 %烟台: 0.2 %玉林: 0.1 %玉林: 0.1 %白山: 0.4 %白山: 0.4 %盐城: 0.1 %盐城: 0.1 %盘锦: 0.7 %盘锦: 0.7 %石嘴山: 0.4 %石嘴山: 0.4 %石家庄: 0.4 %石家庄: 0.4 %福州: 0.7 %福州: 0.7 %秦皇岛: 0.1 %秦皇岛: 0.1 %绵阳: 0.1 %绵阳: 0.1 %自贡: 0.1 %自贡: 0.1 %舟山: 0.1 %舟山: 0.1 %芒廷维尤: 16.3 %芒廷维尤: 16.3 %芜湖: 0.1 %芜湖: 0.1 %芝加哥: 0.4 %芝加哥: 0.4 %苏州: 0.6 %苏州: 0.6 %荆门: 0.7 %荆门: 0.7 %莆田: 2.7 %莆田: 2.7 %营口: 0.5 %营口: 0.5 %衡水: 0.2 %衡水: 0.2 %衡阳: 0.2 %衡阳: 0.2 %衢州: 1.7 %衢州: 1.7 %襄阳: 0.1 %襄阳: 0.1 %西宁: 4.4 %西宁: 4.4 %西安: 0.8 %西安: 0.8 %赣州: 0.1 %赣州: 0.1 %辽阳: 1.3 %辽阳: 1.3 %运城: 0.1 %运城: 0.1 %连云港: 0.2 %连云港: 0.2 %通辽: 0.1 %通辽: 0.1 %遵义: 0.7 %遵义: 0.7 %邯郸: 0.1 %邯郸: 0.1 %邵阳: 0.4 %邵阳: 0.4 %郑州: 0.8 %郑州: 0.8 %郴州: 0.8 %郴州: 0.8 %鄂尔多斯: 1.1 %鄂尔多斯: 1.1 %重庆: 4.0 %重庆: 4.0 %金华: 0.3 %金华: 0.3 %铁岭: 0.3 %铁岭: 0.3 %铜川: 0.2 %铜川: 0.2 %铜陵: 1.0 %铜陵: 1.0 %银川: 0.2 %银川: 0.2 %锡林郭勒盟: 0.1 %锡林郭勒盟: 0.1 %锦州: 0.9 %锦州: 0.9 %长春: 0.7 %长春: 0.7 %长沙: 0.3 %长沙: 0.3 %阜新: 0.1 %阜新: 0.1 %雅加达: 0.1 %雅加达: 0.1 %雅安: 0.2 %雅安: 0.2 %鞍山: 1.7 %鞍山: 1.7 %魁北克: 0.1 %魁北克: 0.1 %黄冈: 0.1 %黄冈: 0.1 %黄石: 0.3 %黄石: 0.3 %其他其他Bass HillChinaIndiaWestbury[]三明三门峡上海东莞临汾丽水乐山佛山保定六安六盘水兰州兴安北京北方邦南充南宁南平南昌南通台州合肥吉林吕梁呼伦贝尔呼和浩特哥伦布唐山商丘嘉兴夏洛特大连天津太原宁德宁波安康宜春宿迁常州常德广元广州延安开普敦张家口徐州德阳怀化成都扬州拉合尔拉贾斯坦邦无锡日照昆明晋城杭州桂林梧州榆林武汉汉中汕头池州沈阳沧州泉州泰州泸州济南海口海得拉巴淮安温州渭南湖州湘潭湘西湘西土家族苗族自治州滁州漯河漳州潍坊烟台玉林白山盐城盘锦石嘴山石家庄福州秦皇岛绵阳自贡舟山芒廷维尤芜湖芝加哥苏州荆门莆田营口衡水衡阳衢州襄阳西宁西安赣州辽阳运城连云港通辽遵义邯郸邵阳郑州郴州鄂尔多斯重庆金华铁岭铜川铜陵银川锡林郭勒盟锦州长春长沙阜新雅加达雅安鞍山魁北克黄冈黄石

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (868) PDF downloads(58) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return